Trump's Drug Price Deal Undermined as Companies Continue Raising Prices, Senate Report Finds
A Senate report has found that some pharmaceutical companies have continued to raise drug prices despite a deal with the Trump administration aimed at bringing them down. One in five American adults report cutting pills in half or skipping doses to save money.
Why it matters
- This update can influence the United Kingdom agenda over the next 24-48 hours.
- It is based on 1 source, which helps cross-check key claims quickly.
- Watch follow-up statements and market/public response to assess real impact.